STERIS (STE) Revenue — Quarter Ended Jun 30, 2024
Revenue for the reporting quarter declined compared to the immediately preceding quarter, but rose compared to the same quarter one year earlier. This reflects a mixed performance relative to recent periods.
Key takeaway
Quarter ended Jun 30, 2024 · FY2025 Q1
Revenue for the reporting quarter declined compared to the immediately preceding quarter, but rose compared to the same quarter one year earlier. This reflects a mixed performance relative to recent periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
-9.9%
Change from the immediately preceding quarter.
Year-over-year
+8.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $1.2B | -5.1% |
| Dec 31, 2023 | $1.3B | +6.7% |
| Mar 31, 2024 | $1.4B | +10.8% |
| Jun 30, 2024 | $1.3B | +8.1% |
Revenue performance
The sequential decline from the prior quarter marks a reversal after several quarters of consecutive growth.
Quarterly comparison
Compared to the preceding quarter, revenue was lower; however, it was higher than in the same period a year ago.
What to watch
The break in the pattern of sequential growth may warrant attention in future quarters.